Illumina Inc. (ILMN)

357.74
3.82 1.06
NASDAQ : Health Technology
Prev Close 361.56
Open 361.60
Day Low/High 357.61 / 363.28
52 Wk Low/High 268.62 / 372.61
Volume 664.96K
Avg Volume 904.90K
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 52.71B
EPS 5.60
P/E Ratio 62.69
Div & Yield N.A. (N.A)
Illumina Moves Up In Analyst Rankings, Passing FedEx

Illumina Moves Up In Analyst Rankings, Passing FedEx

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #81 spot from FedEx Corp , according to ETF Channel. Below is a chart of Illumina Inc versus FedEx Corp plotting their respective rank within the S&P 500 over time (ILMN plotted in blue; FDX plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Gene Editing Offers Promise of Personalized Health Care -- Here's How to Play It

Gene Editing Offers Promise of Personalized Health Care -- Here's How to Play It

CRISPR is a gene-editing technique that uses molecular scissors to precisely snip genetic code. With it, researchers have modified genes to help blind people see, cure sickle cell disease in some patients and speed up the development of numerous new drug treatments.

Illumina Announces A New Genotyping Array And Scientific Contribution To Three Genome Centers To Support The All Of Us Research Program

Illumina Announces A New Genotyping Array And Scientific Contribution To Three Genome Centers To Support The All Of Us Research Program

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

Illumina To Acquire Pacific Biosciences For Approximately $1.2 Billion, Broadening Access To Long-Read Sequencing And Accelerating Scientific Discovery

Illumina To Acquire Pacific Biosciences For Approximately $1.2 Billion, Broadening Access To Long-Read Sequencing And Accelerating Scientific Discovery

Illumina, Inc. (NASDAQ: ILMN) and Pacific Biosciences (NASDAQ:PACB) today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.

Illumina Launches TruSight Oncology 500 To Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

Illumina Launches TruSight Oncology 500 To Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling

Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSight TM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers.

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2018.

Illumina Becomes #33 Most Shorted Nasdaq 100 Component, Replacing Comcast

Illumina Becomes #33 Most Shorted Nasdaq 100 Component, Replacing Comcast

The most recent short interest data has been released for the 09/28/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina To Announce Third Quarter 2018 Financial Results On Tuesday, October 23, 2018

Illumina To Announce Third Quarter 2018 Financial Results On Tuesday, October 23, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2018 following the close of market on Tuesday, October 23, 2018.

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

PepsiCo, GE and just like the weather, the stock market is subject to change.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Illumina Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Cadence Design Systems

Illumina Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Cadence Design Systems

The most recent short interest data has been released for the 09/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Zuora's CEO Tells TheStreet Why He Still Sees a Lot of Room to Grow

Zuora's CEO Tells TheStreet Why He Still Sees a Lot of Room to Grow

The cloud software firm's shares are off sharply due to its guidance. However, CEO Tien Tzuo remains upbeat about the growth of his firm's addressable market.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast.

Illumina Receives Approval Of MiSeq™Dx System In China

Illumina Receives Approval Of MiSeq™Dx System In China

Illumina, Inc. (NASDAQ:ILMN) today announced that its MiSeq™Dx Sequencing System received the approval certificate from the China National Drug Administration (CNDA).

Illumina Announces Pricing Of Convertible Senior Notes

Illumina Announces Pricing Of Convertible Senior Notes

Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.

Illumina To Offer $650 Million Convertible Senior Notes

Illumina To Offer $650 Million Convertible Senior Notes

Illumina, Inc. (Nasdaq: ILMN) today announced its intention to offer, subject to market and other conditions, approximately $650 million aggregate principal amount of convertible senior notes due 2023 (the "Notes").

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of fiscal year 2018.

Jim's Daily Rundown

Jim discusses his interview with Larry Kudlow at the Delivering Alpha conference, Nucor's earnings, Danaher's earnings and announced spin, Abbott Labs, and Comcast!

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Some beaten up biotech names are finally coming back to life. Here's a look at the technical analysis.

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Investors have never gone wrong buying Netflix on the dips. Jim Cramer tells you what to make of the 'FANG Musketeers.'

Illumina To Announce Second Quarter 2018 Financial Results On Monday, July 30, 2018

Illumina To Announce Second Quarter 2018 Financial Results On Monday, July 30, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2018 following the close of market on Monday, July 30, 2018.

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Look for gains in Illumina shares to $300 and then perhaps around $340.

Consider Going Long Illumina

Consider Going Long Illumina

Illumina could offer a profitable sequence.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC has commenced an investigation of Illumina, Inc. ("Illumina" or the "Company") (Nasdaq: ILMN) on behalf of the Company's stockholders.

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina, Inc. (NASDAQ: ILMN) today announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS).

TheStreet Quant Rating: B (Buy)